Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Diamond Therapeutics logo — Revolutionizing the treatment of mental health

Diamond Therapeutics

Revolutionizing the treatment of mental health

Founded 2018 Canada Toronto, Canada 9 employees Series Unknown Biotechnology, Health Care +2

General Information

Company Name Diamond Therapeutics
Founded Year 2018
Location Canada Toronto, Canada +1
Employees 9
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series Unknown
Social

Get notified when Diamond Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Diamond Therapeutics

Diamond Therapeutics is a biotechnology startup headquartered in Canada, founded in 2018. The company is revolutionizing the treatment of mental health through the development of safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. Their focus is on sub-perceptual psilocybin-based medicines, aiming to deliver greater impact than current first-line treatments without perceptual side effects. The recent Venture Round investment at 04 April 2023 saw participation from Noetic Fund and First Avenue Ventures. With a mission to unlock the promise of a new and better class of mental health therapies, Diamond Therapeutics is poised to make a significant impact in the biotechnology and healthcare industries.

Taxonomy: psychopharmacology, life sciences, neuropsychiatry, drug development, clinical trials, clinical drug development, psychedelic medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 2
Investor Investor
04 Apr 2023
Venture Round •••••• 1 •••• •••• 07 Jan 2021

Diamond Therapeutics Alternatives & Competitors

Diamond Therapeutics vs
Symberix
Symberix United States

Pharmaceutical Control of the Microbiome

3 employees
Biotechnology, Health Care
Diamond Therapeutics vs
Consegna Pharma Inc.
Consegna Pharma Inc.

Crafting the future of healthcare with innovative long-acting injectable medications for better clin...

Grant
6 employees
Biotechnology, Pharmaceutical
Diamond Therapeutics vs
MindMed
MindMed United States

MindMed is a clinical-stage biopharma company developing novel products to treat brain health disord...

Post Ipo Equity
103 employees
Biotechnology, Health Care

FAQ About Diamond Therapeutics

Revolutionizing the treatment of mental health
Diamond Therapeutics was founded in 2018.
Diamond Therapeutics is headquartered in Toronto, Canada.
Diamond Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences.
Diamond Therapeutics has approximately 9 employees.
Diamond Therapeutics has completed 2 funding rounds. The latest funding stage is Series Unknown.
Top alternatives and competitors to Diamond Therapeutics include Symberix, Consegna Pharma Inc., MindMed, Vitalis Pharma, GoodCap Pharmaceuticals Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diamond Therapeutics and Symberix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Diamond Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy